UK clinical research woos Indian students
According to ICRI chairman UK employs more than 72,000 clinical research technicians, and the current trend is towards hiring from countries such as India, reports Suprotip Ghosh.business Updated: Oct 02, 2007 21:48 IST
Indian students are hot property in the world's booming clinical research market, and there is a major requirement in the United Kingdom, the world's second largest market in clinical research.
The UK employs more than 72,000 clinical research technicians, and the current trend is towards hiring from countries such as India, said Shiv Duggal, chairman, Institute for Clinical Research India (ICRI).
To cope with this demand, ICRI has announced that it would open a campus in the Cavendish College, London. ICRI also announced the launch of a global Post Graduate Diploma in Clinical Research in association with Institute of Clinical Research -UK.
Details are available on the website
Clinical research professionals are required for drug trials. According to internationally accepted norms, any new medicine has to be thoroughly tested in various stages before it is marketed. These tests, which have to be run in thousands of patients all over the world, are known as trials.
More than 60 new companies have come up in India in the field of clinical research in India between 2005 and 2007.
According to a Goldman Sachs report quoted by Duggal, the size of the industry was close to $16.3 billion in 2007.
India alone would need more than 50,000 clinical research professionals in the next three years.
Few institutes in India cater to the clinical trials and academic healthcare market, claims AK Nair, president, ICRI.
"There are a few other institutes in India, but the real demand is much, much higher," he said.
There are high-end jobs in consultancies such as Accenture, as there are jobs in trial sites, for nurses and data entry operators, he says. Clinical trials and research can be a highly remunerative field, as close to 30 per cent of a medicine's development cost is in its trials, which need to establish safety and efficacy before it can be marketed. The estimated cost of developing a new drug today is close to $ 1,200 million.